This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
The SP 500 index level can hint at breadth and momentum, helping you gauge whether moves are broad-based or narrow.
23,589 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A high-profile insider move raises questions about strategy and sentiment. This article breaks down the Paychex share...
A bold shift in AI strategy rewrite the investment thesis around Alphabet. OpenAI exits the AI video space, creating ...
MP Materials is shaping the materials landscape with its Mountain Pass operation. This guide breaks down what to wat...
Realty Income raised dividend for the 113th consecutive time, but the stock trades at rich valuations with rising lev...
As AI reshapes legal work, professors debate its limits in reasoning. This article examines why lawyers already bette...
Coinbase is expanding beyond its USDC partnership by joining a large coalition backing a new stablecoin. This shift c...
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
A notable new stake in Kyndryl signals growing confidence from a private equity–style shop. This deep dive explains w...
Meta Platforms Just Unveiled AI chips signals a new era in AI hardware. This piece breaks down what it means for Nvid...
Druski’s latest skit already exploded across social media, showing how fast virality can translate into income—if you...
A massive AI-driven data center build-out is changing how investors think about tech stocks. This piece explains the ...